Also, although our study focused on ACC and SCLC, our screening data revealed high DLK1 expression across several additional metastatic tumor types such as germ cell tumors and sarcomas and recent parallel work has demonstrated DLK1 as an immunotherapeutic cell surface target in pediatric neuroblastoma9. Here, DLK1 is linked to sarcoma.